Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease.

By M. Dubinsky, Stéphanie Lamothe, Huiying Yang, S. Targan, D. Sinnett, Y. Théorêt, E. Seidman. Gastroenterology, 2000

1,011 citations recorded by the source corpus.

Subfields: Genetics, Hematology, Public Health, Environmental and Occupational Health

View Paper: https://www.semanticscholar.org/paper/9d8279813fda1c4e2b7fd1e8fed9156903a9be3d

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. D. Sachar
2. A. Kornbluth

Citations in the corpus

• Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee (2010, background): “Although the thiopurine metabolite 6-methylmercaptopurine (6-MMP) has been associated with elevated transaminases (”